Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
IOrganBio Launches From Stealth with $2M Seed Round Led by First Star Ventures
SeedVenture Capital

IOrganBio Launches From Stealth with $2M Seed Round Led by First Star Ventures

•October 29, 2025
•Oct 29, 2025
0

Participants

iOrganBio

iOrganBio

company

First Star

First Star

investor

IndieBio

IndieBio

investor

Cape Fear BioCapital

Cape Fear BioCapital

investor

2ndF

2ndF

investor

Terasaki Institute

Terasaki Institute

investor

Alix Ventures

Alix Ventures

investor

Why It Matters

The financing underscores growing investor confidence in cell‑manufacturing platforms, which could accelerate scalable human cell production and reshape biotech pipelines and drug development.

Deal Summary

iOrganBio announced its launch from stealth and a $2 million seed funding round to transform how human cells are made. The round was led by First Star Ventures with participation from IndieBio, Cape Fear BioCapital, 2ndF, Terasaki Institute, and Alix Ventures.

0

Comments

Want to join the conversation?

Loading comments...